| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.60e-07 | 16 | 25 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.27e-06 | 21 | 25 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.60e-04 | 85 | 25 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.74e-04 | 102 | 25 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.82e-04 | 20 | 25 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.18e-04 | 1160 | 25 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.06e-03 | 1356 | 25 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.10e-03 | 372 | 25 | 4 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.41e-03 | 398 | 25 | 4 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.65e-03 | 473 | 25 | 4 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 3.52e-03 | 512 | 25 | 4 | GO:0019787 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.67e-03 | 1244 | 25 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 4.04e-03 | 532 | 25 | 4 | GO:0016755 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 4.08e-03 | 1271 | 25 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.41e-03 | 891 | 25 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | amide binding | 5.99e-03 | 299 | 25 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 7.10e-03 | 318 | 25 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 7.22e-03 | 320 | 25 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 7.60e-03 | 326 | 25 | 3 | GO:0001217 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 7.98e-03 | 1459 | 25 | 6 | GO:0000977 | |
| Domain | Ldl_recept_b | 6.72e-07 | 14 | 24 | 3 | PF00058 | |
| Domain | LDLRB | 6.72e-07 | 14 | 24 | 3 | PS51120 | |
| Domain | LY | 8.40e-07 | 15 | 24 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 8.40e-07 | 15 | 24 | 3 | IPR000033 | |
| Domain | DUF5050 | 1.58e-06 | 2 | 24 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.58e-06 | 2 | 24 | 2 | PF16472 | |
| Domain | PHD | 4.76e-06 | 89 | 24 | 4 | SM00249 | |
| Domain | Znf_PHD | 5.20e-06 | 91 | 24 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.17e-06 | 95 | 24 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.44e-06 | 96 | 24 | 4 | PS01359 | |
| Domain | - | 1.65e-05 | 39 | 24 | 3 | 2.120.10.30 | |
| Domain | - | 1.74e-05 | 449 | 24 | 6 | 3.30.40.10 | |
| Domain | LDLR_class-A_CS | 1.79e-05 | 40 | 24 | 3 | IPR023415 | |
| Domain | Znf_RING/FYVE/PHD | 1.97e-05 | 459 | 24 | 6 | IPR013083 | |
| Domain | Ldl_recept_a | 2.55e-05 | 45 | 24 | 3 | PF00057 | |
| Domain | - | 2.73e-05 | 46 | 24 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.73e-05 | 46 | 24 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 3.10e-05 | 48 | 24 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.30e-05 | 49 | 24 | 3 | IPR002172 | |
| Domain | LDLa | 3.30e-05 | 49 | 24 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.30e-05 | 49 | 24 | 3 | PS50068 | |
| Domain | Znf_FYVE_PHD | 3.46e-05 | 147 | 24 | 4 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 7.73e-05 | 65 | 24 | 3 | IPR019786 | |
| Domain | PHD | 1.18e-04 | 75 | 24 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.38e-04 | 79 | 24 | 3 | IPR019787 | |
| Domain | EGF_CA | 1.78e-04 | 86 | 24 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.54e-04 | 97 | 24 | 3 | IPR018097 | |
| Domain | EGF_CA | 2.70e-04 | 99 | 24 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.78e-04 | 100 | 24 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.30e-04 | 106 | 24 | 3 | IPR000152 | |
| Domain | EPHD | 3.60e-04 | 22 | 24 | 2 | PS51805 | |
| Domain | EGF_CA | 4.98e-04 | 122 | 24 | 3 | SM00179 | |
| Domain | cEGF | 5.05e-04 | 26 | 24 | 2 | IPR026823 | |
| Domain | cEGF | 5.05e-04 | 26 | 24 | 2 | PF12662 | |
| Domain | EGF-like_Ca-bd_dom | 5.22e-04 | 124 | 24 | 3 | IPR001881 | |
| Domain | EGF | 5.47e-04 | 126 | 24 | 3 | PF00008 | |
| Domain | RING | 5.72e-04 | 305 | 24 | 4 | SM00184 | |
| Domain | Znf_RING | 7.35e-04 | 326 | 24 | 4 | IPR001841 | |
| Domain | Growth_fac_rcpt_ | 1.02e-03 | 156 | 24 | 3 | IPR009030 | |
| Domain | p53-like_TF_DNA-bd | 2.10e-03 | 53 | 24 | 2 | IPR008967 | |
| Domain | zf-C3HC4 | 2.82e-03 | 223 | 24 | 3 | PF00097 | |
| Domain | EGF_3 | 3.27e-03 | 235 | 24 | 3 | PS50026 | |
| Domain | EGF | 3.27e-03 | 235 | 24 | 3 | SM00181 | |
| Domain | EGF-like_dom | 3.85e-03 | 249 | 24 | 3 | IPR000742 | |
| Domain | EGF_1 | 4.12e-03 | 255 | 24 | 3 | PS00022 | |
| Domain | EGF-like_CS | 4.39e-03 | 261 | 24 | 3 | IPR013032 | |
| Domain | EGF_2 | 4.59e-03 | 265 | 24 | 3 | PS01186 | |
| Domain | ZF_RING_1 | 5.95e-03 | 291 | 24 | 3 | PS00518 | |
| Domain | ZF_RING_2 | 6.35e-03 | 298 | 24 | 3 | PS50089 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 3.64e-08 | 1489 | 25 | 10 | 28611215 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.33e-07 | 21 | 25 | 3 | 21337463 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 4.96e-07 | 2 | 25 | 2 | 15963947 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 4.96e-07 | 2 | 25 | 2 | 12871934 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 34905470 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 1.49e-06 | 3 | 25 | 2 | 24251389 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 12807892 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 15591119 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.72e-06 | 608 | 25 | 6 | 36089195 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 16101684 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 17567906 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 23386606 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 12169628 | ||
| Pubmed | Disruption of MeCP2-TCF20 complex underlies distinct neurodevelopmental disorders. | 1.39e-05 | 8 | 25 | 2 | 35074918 | |
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 10380922 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 23986861 | ||
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 20005821 | ||
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 28361920 | ||
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 24425205 | ||
| Pubmed | 2.72e-05 | 11 | 25 | 2 | 24639464 | ||
| Pubmed | Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function. | 3.85e-05 | 13 | 25 | 2 | 30840660 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 4.49e-05 | 14 | 25 | 2 | 17389516 | |
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 15082773 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 5.22e-05 | 101 | 25 | 3 | 23382219 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 10827173 | ||
| Pubmed | 8.42e-05 | 19 | 25 | 2 | 16697675 | ||
| Pubmed | 8.80e-05 | 332 | 25 | 4 | 37433992 | ||
| Pubmed | 1.14e-04 | 22 | 25 | 2 | 33304758 | ||
| Pubmed | 1.15e-04 | 689 | 25 | 5 | 36543142 | ||
| Pubmed | 1.24e-04 | 23 | 25 | 2 | 38828908 | ||
| Pubmed | 1.31e-04 | 709 | 25 | 5 | 22988430 | ||
| Pubmed | 2.41e-04 | 808 | 25 | 5 | 20412781 | ||
| Pubmed | 3.43e-04 | 38 | 25 | 2 | 29799838 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 3.52e-04 | 877 | 25 | 5 | 20211142 | |
| Pubmed | Heterozygous variants in SIX3 and POU1F1 cause pituitary hormone deficiency in mouse and man. | 4.82e-04 | 45 | 25 | 2 | 35951005 | |
| Pubmed | 5.71e-04 | 49 | 25 | 2 | 24652767 | ||
| Pubmed | 6.19e-04 | 51 | 25 | 2 | 30478225 | ||
| Interaction | H3C3 interactions | 2.54e-05 | 495 | 25 | 6 | int:H3C3 | |
| Interaction | VIT interactions | 3.09e-05 | 7 | 25 | 2 | int:VIT | |
| Interaction | ZFP41 interactions | 4.72e-05 | 57 | 25 | 3 | int:ZFP41 | |
| Interaction | APBB1 interactions | 9.17e-05 | 195 | 25 | 4 | int:APBB1 | |
| Interaction | ZNF563 interactions | 9.68e-05 | 12 | 25 | 2 | int:ZNF563 | |
| Interaction | HMGA1 interactions | 1.43e-04 | 419 | 25 | 5 | int:HMGA1 | |
| Interaction | APBB2 interactions | 1.50e-04 | 84 | 25 | 3 | int:APBB2 | |
| Interaction | SCN3A interactions | 1.75e-04 | 16 | 25 | 2 | int:SCN3A | |
| Interaction | MDK interactions | 1.91e-04 | 91 | 25 | 3 | int:MDK | |
| Interaction | ZNF330 interactions | 1.91e-04 | 446 | 25 | 5 | int:ZNF330 | |
| Interaction | CAV1 interactions | 2.08e-04 | 724 | 25 | 6 | int:CAV1 | |
| Interaction | CLU interactions | 2.21e-04 | 245 | 25 | 4 | int:CLU | |
| Interaction | ASF1A interactions | 2.35e-04 | 249 | 25 | 4 | int:ASF1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q35 | 7.24e-03 | 235 | 25 | 2 | chr5q35 | |
| GeneFamily | Low density lipoprotein receptors | 1.96e-07 | 13 | 17 | 3 | 634 | |
| GeneFamily | PHD finger proteins | 7.71e-05 | 90 | 17 | 3 | 88 | |
| GeneFamily | Ring finger proteins | 2.02e-03 | 275 | 17 | 3 | 58 | |
| GeneFamily | Ankyrin repeat domain containing | 2.13e-02 | 242 | 17 | 2 | 403 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.80e-02 | 718 | 17 | 3 | 28 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.15e-06 | 200 | 25 | 5 | M9549 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.96e-05 | 498 | 25 | 6 | PCBC_ratio_EB_vs_SC_500 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.83e-08 | 193 | 25 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.27e-06 | 185 | 25 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 25 | 4 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.49e-06 | 188 | 25 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.79e-06 | 192 | 25 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.11e-06 | 196 | 25 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.28e-06 | 198 | 25 | 4 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 4.37e-06 | 199 | 25 | 4 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 4.37e-06 | 199 | 25 | 4 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 199 | 25 | 4 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Sigmoid-T_cell-Tcm|T_cell / Region, Cell class and subclass | 4.37e-06 | 199 | 25 | 4 | acdf95f4d58df47690f4ae254245bc618f9ac07e | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.06e-05 | 129 | 25 | 3 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.23e-05 | 152 | 25 | 3 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 8.89e-05 | 156 | 25 | 3 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 8.89e-05 | 156 | 25 | 3 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 9.06e-05 | 157 | 25 | 3 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-05 | 159 | 25 | 3 | edc193187fedaf5b1d8891231cf862a177eafb64 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.41e-05 | 159 | 25 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 166 | 25 | 3 | c22a97353f7eb084f768c13d7767a80b30f05043 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 166 | 25 | 3 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 166 | 25 | 3 | 01544c851588f1cde05d6700c3d1167f70a0fbd5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 167 | 25 | 3 | 4e613be2b3ba01160b0c0254fce3c4f72220e580 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 167 | 25 | 3 | c7d1e84af1f4d7430858287520ac2cfa36203642 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 167 | 25 | 3 | 18ad85751bd892309627eefc357eb28ec5a7c300 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 169 | 25 | 3 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 169 | 25 | 3 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 170 | 25 | 3 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 170 | 25 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 171 | 25 | 3 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 171 | 25 | 3 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 172 | 25 | 3 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 172 | 25 | 3 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 173 | 25 | 3 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 173 | 25 | 3 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-04 | 173 | 25 | 3 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 174 | 25 | 3 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 175 | 25 | 3 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 175 | 25 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 176 | 25 | 3 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 176 | 25 | 3 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 176 | 25 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 176 | 25 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 176 | 25 | 3 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 176 | 25 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 176 | 25 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 177 | 25 | 3 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 177 | 25 | 3 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.31e-04 | 178 | 25 | 3 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 1.31e-04 | 178 | 25 | 3 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.34e-04 | 179 | 25 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 180 | 25 | 3 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 180 | 25 | 3 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 180 | 25 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 180 | 25 | 3 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 181 | 25 | 3 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.38e-04 | 181 | 25 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 182 | 25 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 182 | 25 | 3 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.43e-04 | 183 | 25 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 1.43e-04 | 183 | 25 | 3 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.43e-04 | 183 | 25 | 3 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.45e-04 | 184 | 25 | 3 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.46e-04 | 32 | 25 | 2 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.46e-04 | 32 | 25 | 2 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.47e-04 | 185 | 25 | 3 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-04 | 185 | 25 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.47e-04 | 185 | 25 | 3 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 1.47e-04 | 185 | 25 | 3 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.50e-04 | 186 | 25 | 3 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.50e-04 | 186 | 25 | 3 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 1.50e-04 | 186 | 25 | 3 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 186 | 25 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 1.52e-04 | 187 | 25 | 3 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.52e-04 | 187 | 25 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-04 | 187 | 25 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.54e-04 | 188 | 25 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.54e-04 | 188 | 25 | 3 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 188 | 25 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.57e-04 | 189 | 25 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 189 | 25 | 3 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 25 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.59e-04 | 190 | 25 | 3 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.59e-04 | 190 | 25 | 3 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| Disease | microcephaly (is_implicated_in) | 1.77e-05 | 8 | 24 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Alzheimer disease, APOE carrier status | 6.83e-05 | 98 | 24 | 3 | EFO_0007659, MONDO_0004975 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.65e-04 | 132 | 24 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | melanoma (is_implicated_in) | 3.50e-04 | 34 | 24 | 2 | DOID:1909 (is_implicated_in) | |
| Disease | dental caries | 4.60e-04 | 187 | 24 | 3 | EFO_0003819 | |
| Disease | brain volume measurement | 1.26e-03 | 595 | 24 | 4 | EFO_0006930 | |
| Disease | cortical thickness | 1.77e-03 | 1113 | 24 | 5 | EFO_0004840 | |
| Disease | myocardial infarction (is_implicated_in) | 2.93e-03 | 99 | 24 | 2 | DOID:5844 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETKKDHPKTGAKTDC | 231 | Q92870 | |
| AAPADKGRKHECSKE | 1796 | Q7Z5J4 | |
| FDSEHSADEKEKPCA | 481 | Q96L73 | |
| KKGDKETDPDFDHCA | 251 | Q86XS8 | |
| DGIPHCKDKSDEKLL | 2531 | Q9NZR2 | |
| DDSCDGFKDLIKPHE | 621 | Q8NEM0 | |
| SLGSDGKSCKKPEHE | 511 | Q07954 | |
| DEDHSSPASEGGCKK | 256 | O94880 | |
| DGSKKHPARTCDDLK | 1286 | P05997 | |
| SDSEAEKKCDGPDHK | 691 | Q5T7N3 | |
| AEKTTNGHKTDPDCK | 496 | Q6ZVF9 | |
| SCSEKAAPHKAEGLE | 231 | Q9BV36 | |
| DCLDHSDEDDCPKKT | 71 | Q14114 | |
| SEGDEDCLPASKKAK | 251 | P78346 | |
| SKEEHGPEACDAAKI | 381 | O15119 | |
| DKEADKDCLPFAKDD | 211 | Q7Z6J0 | |
| CPSDKDKSPESHKAK | 16 | Q5T681 | |
| DCDAPSHNSEKKKTE | 881 | O15164 | |
| EGKHCFAKEDDPEKF | 126 | Q0IIM8 | |
| CSRDHSMEDPDKKGE | 406 | Q9C0C9 | |
| KRKKGAHEDCDEEPQ | 1086 | Q9BY07 | |
| DKDEAVKECGKESPH | 606 | Q9NRE2 | |
| HTKEKPSKSEECDKA | 876 | Q05481 | |
| HTGEKPFKCDECDKT | 356 | Q99676 | |
| DTESKKDPEGCDKSD | 436 | P19838 |